Searched for
GLENMARK PHARMACEUTICALS NEWS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Capitalmind Flexi Cap Fund exits RIL and 2 others, hikes stake in Titan Company, MCX and 16 other stocks in AprilCapitalmind Flexi Cap Fund exited Reliance Industries, Bank of Baroda, and L&T Finance in April. The fund also increased stakes in Titan Co...
- Nifty finds support: Nagaraj Shetti spots 2 breakout stocks worth watchingNifty's Monday pullback is a technical dip, not a trend reversal, says HDFC Securities analyst Nagaraj Shetti. After forming a higher botto...
- US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip BandyopadhyayIndian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expe...
- Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in USGlenmark share price: The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark Pharm...
- Reduce Glenmark Pharmaceuticals, target price Rs 780: ICICI SecuritiesGlenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the y...
- Reduce Glenmark Pharmaceuticals, target price Rs 660: ICICI SecuritiesGlenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the y...
- Glenmark Pharma to sell 75% stake in Glenmark Life to Nirma for Rs 5,652 croreGlenmark Pharmaceuticals will sell 9,18,95,379 shares in the subsidiary at Rs 615 a share. The 75% stake sale in Glenmark Life Sciences wil...
- Glenmark settles drug pricing case with US Department of JusticeUS-based Glenmark Pharmaceuticals Inc, a subsidiary of the company, has entered into a three-year deferred prosecution agreement with DOJ i...
- Accumulate Glenmark Pharmaceuticals, target price Rs 460: Prabhudas LilladherGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11615.45 Crore) operating in ...
- Buy Glenmark Pharmaceuticals, target price Rs 440: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11089.21 Crore) operating in ...
- Hold Glenmark Pharmaceuticals, target price Rs 440: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11075.10 Crore) operating in ...
- Pharma stocks bleed as US states file lawsuit against generic drug firmsLupin, Aurobindo Pharma, Dr Reddy’s, Glenmark, Wockhardt USA and Zydus have been named in the lawsuit.
- True North in talks to buy into Glenmark’s API biz for Rs 1500 crIf successful, the transaction will help Glen Saldhana-controlled company to make a bigger step in the API business through rapid expansion...
- True North could buy a chunk of Glenmark’s API biz for Rs 1,500 croreThe company has mandated Avendus Capital to run a formal process to find a buyer.
- Prefer Glenmark on strong molecule pipeline; Sun Pharma a value arbitrage opportunity: Prakash DiwanThere are certain smaller names as well, which would start bouncing back, believes Diwan. The analyst pointed out that Suven Life has falle...
- Glenmark Pharmaceuticals gains 7% on Q2 results; brokerages maintain buyThe company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statemen...
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- No-win situation for pharma companies as Rupee slides against DollarIt is turning out to be a no-win situation for pharmaceutical companies as the rupee depreciates against the dollar.
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
Load More
